Cancer
is
a
daunting
global
health
problem
with
steadily
rising
incidence.
Despite
the
wide
arsenal
of
current
anticancer
therapies,
challenges
such
as
drug
resistance,
tumor
heterogeneity,
poor
targeting,
and
severe
side
effects
often
lead
to
suboptimal
efficacy
patient
outcomes,
highlighting
need
for
innovative
therapies.
Autophagy
modulation
has
emerged
an
attractive
approach
complement
existing
The
dual
role
autophagy
in
cancer
promotion
suppression
inspired
development
new
drugs
therapeutic
strategies
focusing
on
both
inhibition
induction.
promising
results
modulators
preclinical
studies,
lack
selectivity
potency,
toxicity,
pharmacokinetics,
inadequate
targeting
continue
limit
their
successful
clinical
translation.
Many
these
could
be
overcome
using
nanomedicine.
This
review
explores
recent
advancements
nanomedicine
modulation.
Successful
combination
leveraging
nanoparticles
synergy
chemotherapy,
immunotherapy,
phototherapy,
gene
therapy,
other
modalities
are
presented.
Additionally,
nanomaterials
intrinsic
autophagy‐modulating
capabilities,
self‐assembling
inhibitors,
discussed.
Finally,
limitations
currently
trials
discussed,
future
perspectives
designing
implementation
explored.
Cancer Letters,
Год журнала:
2024,
Номер
587, С. 216659 - 216659
Опубликована: Фев. 15, 2024
Despite
the
challenges
posed
by
drug
resistance
and
side
effects,
chemotherapy
remains
a
pivotal
strategy
in
cancer
treatment.
A
key
issue
this
context
is
macroautophagy
(commonly
known
as
autophagy),
dysregulated
cell
death
mechanism
often
observed
during
chemotherapy.
Autophagy
plays
cytoprotective
role
maintaining
cellular
homeostasis
recycling
organelles,
emerging
evidence
points
to
its
significant
promoting
progression.
Cisplatin,
DNA-intercalating
agent
for
inducing
cycle
arrest,
encounters
treatments.
Recent
studies
have
shown
that
autophagy
can
contribute
cisplatin
or
insensitivity
tumor
cells
through
various
mechanisms.
This
be
mediated
protective
autophagy,
which
suppresses
apoptosis.
Additionally,
autophagy-related
changes
metastasis,
particularly
induction
of
Epithelial-Mesenchymal
Transition
(EMT),
also
lead
resistance.
Nevertheless,
pharmacological
strategies
targeting
regulation
apoptosis
offer
promising
avenues
enhance
sensitivity
therapy.
Notably,
numerous
non-coding
RNAs
been
identified
regulators
Thus,
therapeutic
associated
pathways
holds
potential
restoring
sensitivity,
highlighting
an
important
direction
future
clinical
research.
Macroautophagy/autophagy
is
an
evolutionally
conserved
catabolic
process
in
which
cytosolic
contents,
such
as
aggregated
proteins,
dysfunctional
organelle,
or
invading
pathogens,
are
sequestered
by
the
double-membrane
structure
termed
autophagosome
and
delivered
to
lysosome
for
degradation.
Over
past
two
decades,
autophagy
has
been
extensively
studied,
from
molecular
mechanisms,
biological
functions,
implications
various
human
diseases,
development
of
autophagy-related
therapeutics.
This
review
will
focus
on
latest
research,
covering
mechanisms
control
biogenesis
autophagosome-lysosome
fusion,
upstream
regulatory
pathways
including
AMPK
MTORC1
pathways.
We
also
provide
a
systematic
discussion
implication
cancer,
neurodegenerative
disorders
(Alzheimer
disease,
Parkinson
Huntington's
Amyotrophic
lateral
sclerosis),
metabolic
diseases
(obesity
diabetes),
viral
infection
especially
SARS-Cov-2
COVID-19,
cardiovascular
(cardiac
ischemia/reperfusion
cardiomyopathy),
aging.
Finally,
we
summarize
pharmacological
agents
that
have
therapeutic
potential
clinical
applications
via
targeting
pathway.
It
believed
decades
hard
work
research
eventually
bring
real
tangible
benefits
improvement
health
diseases.
Cells,
Год журнала:
2023,
Номер
12(3), С. 458 - 458
Опубликована: Янв. 31, 2023
Recent
evidence
suggests
that
autophagy
is
a
governed
catabolic
framework
enabling
the
recycling
of
nutrients
from
injured
organelles
and
other
cellular
constituents
via
lysosomal
breakdown.
This
mechanism
has
been
associated
with
development
various
pathologic
conditions,
including
cancer
neurological
disorders;
however,
recently
updated
studies
have
indicated
plays
dual
role
in
cancer,
acting
as
cytoprotective
or
cytotoxic
mechanism.
Numerous
preclinical
clinical
investigations
shown
inhibiting
enhances
an
anticancer
medicine’s
effectiveness
malignancies.
Autophagy
antagonists,
chloroquine
hydroxychloroquine,
previously
authorized
trials,
encouraging
medication-combination
therapies
targeting
autophagic
processes
for
cancer.
In
this
review,
we
provide
update
on
recent
research
examining
efficacy
combining
drugs
activate
inhibitors.
Additionally,
highlight
difficulties
progress
toward
using
treatment
strategy.
Importantly,
must
enable
use
suitable
inhibitors
coadministration
delivery
systems
conjunction
agents.
Therefore,
review
briefly
summarizes
general
molecular
process
behind
its
bifunctional
important
suppression
tumor
growth
resistance
to
chemotherapy
metastasis
regulation.
We
then
emphasize
how
cells
interacting
one
another
promising
therapeutic
target
treatment.
Biology,
Год журнала:
2023,
Номер
12(4), С. 558 - 558
Опубликована: Апрель 6, 2023
Background:
Senescence
is
a
cellular
aging
process
in
all
multicellular
organisms.
It
characterized
by
decline
functions
and
proliferation,
resulting
increased
damage
death.
These
conditions
play
an
essential
role
significantly
contribute
to
the
development
of
age-related
complications.
Humanin
mitochondrial-derived
peptide
(MDP),
encoded
mitochondrial
DNA,
playing
cytoprotective
preserve
function
cell
viability
under
stressful
senescence
conditions.
For
these
reasons,
humanin
can
be
exploited
strategies
aiming
counteract
several
processes
involved
aging,
including
cardiovascular
disease,
neurodegeneration,
cancer.
Relevance
disease:
appears
decay
organ
tissue
function,
it
has
also
been
related
diseases,
such
as
conditions,
cancer,
diabetes.
In
particular,
senescent
cells
produce
inflammatory
cytokines
other
pro-inflammatory
molecules
that
participate
diseases.
Humanin,
on
hand,
seems
contrast
known
diseases
promoting
death
damaged
or
malfunctioning
contributing
inflammation
often
associated
with
them.
Both
humanin-related
mechanisms
are
complex
have
not
fully
clarified
yet.
Further
research
needed
thoroughly
understand
disease
identify
potential
interventions
target
them
order
prevent
treat
Objectives:
This
systematic
review
aims
assess
underlying
link
connecting
senescence,
humanin,
disease.
Autophagy,
Год журнала:
2024,
Номер
20(12), С. 2655 - 2676
Опубликована: Июль 25, 2024
Spautin-1
is
a
well-known
macroautophagy/autophagy
inhibitor
via
suppressing
the
deubiquitinases
USP10
and
USP13
promoting
degradation
of
PIK3C3/VPS34-BECN1
complex,
while
its
effect
on
selective
autophagy
remains
poorly
understood.
Mitophagy
form
for
removal
damaged
superfluous
mitochondria
autophagy-lysosome
pathway.
Here,
we
report
surprising
discovery
that,
spautin-1
as
an
effective
inhibitor,
it
promotes
PINK1-PRKN-dependent
mitophagy
induced
by
mitochondrial
damage
agents.
Mechanistically,
facilitates
stabilization
activation
full-length
PINK1
at
outer
membrane
(OMM)
binding
to
components
TOMM
complex
(TOMM70
TOMM20),
leading
disruption
import
prevention
PARL-mediated
cleavage.
Moreover,
induces
neuronal
in
Nutrients,
Год журнала:
2022,
Номер
14(21), С. 4655 - 4655
Опубликована: Ноя. 3, 2022
Intermittent
fasting
is
a
non-pharmacological
dietary
approach
to
management
of
obesity
and
metabolic
syndrome,
involving
periodic
intervals
complete
or
near-complete
abstinence
from
food
energy-containing
fluids.
This
strategy
has
recently
gained
significant
popularity
in
mainstream
culture
been
shown
induce
weight
loss
humans,
reduce
gut
systemic
inflammation,
improve
microbial
diversity
dysbiosis
(largely
animal
models).
It
hypothesized
that
intermittent
could
be
beneficial
the
nonalcoholic
fatty
liver
disease,
given
condition's
association
with
obesity.
review
summarizes
protocols,
potential
mechanisms
action,
evidence
for
disease.
also
highlights
practical
considerations
implementing
clinical
practice.
A
search
literature
English-language
articles
related
time-restricted
feeding
disease
was
completed
PubMed
Google
Scholar.
Potential
action
effects
included
modulation
circadian
rhythm,
adipose
tissue
adipokines,
microbiome,
autophagy.
Preclinical,
epidemiological,
trial
data
suggested
benefits
on
inflammatory
markers
humans.
However,
there
paucity
its
patients
More
studies
are
needed
determine
evaluate
safety
efficacy
this
population.
Cells,
Год журнала:
2023,
Номер
12(3), С. 475 - 475
Опубликована: Фев. 1, 2023
Recent
evidence
points
to
autophagy
as
an
essential
cellular
requirement
for
achieving
the
mature
structure,
homeostasis,
and
transparency
of
lens.
Collective
from
multiple
laboratories
using
chick,
mouse,
primate,
human
model
systems
provides
that
classic
structures,
ranging
double-membrane
autophagosomes
single-membrane
autolysosomes,
are
found
throughout
lens
in
both
undifferentiated
epithelial
cells
maturing
fiber
cells.
Recently,
key
signaling
pathways
have
been
identified
initiate
critical
steps
differentiation
program,
including
elimination
organelles
form
core
organelle-free
zone.
Other
recent
studies
ex
vivo
culture
demonstrate
low
oxygen
environment
drives
HIF1a-induced
via
upregulation
mitophagy
components
direct
specific
mitochondria,
endoplasmic
reticulum,
Golgi
apparatus
during
cell
differentiation.
Pioneering
on
structural
requirements
nuclei
reveal
presence
entirely
novel
structure
associated
with
degrading
termed
nuclear
excisosome.
Considerable
also
indicates
is
a
differentiation,
transparency,
since
mutation
proteins
results
cataract
formation.
Frontiers in Cellular Neuroscience,
Год журнала:
2023,
Номер
17
Опубликована: Март 16, 2023
The
proper
functioning
of
the
cell
clearance
machinery
is
critical
for
neuronal
health
within
central
nervous
system
(CNS).
In
normal
physiological
conditions,
actively
involved
in
elimination
misfolded
and
toxic
proteins
throughout
lifetime
an
organism.
highly
conserved
regulated
pathway
autophagy
one
important
processes
preventing
neutralizing
pathogenic
buildup
that
could
eventually
lead
to
development
neurodegenerative
diseases
(NDs)
such
as
Alzheimer's
disease
or
Amyotrophic
lateral
sclerosis
(ALS).
most
common
genetic
cause
ALS
frontotemporal
dementia
(FTD)
a
hexanucleotide
expansion
consisting
GGGGCC
(G4C2)
repeats
chromosome
9
open
reading
frame
72
gene
(C9ORF72).
These
abnormally
expanded
have
been
implicated
leading
three
main
modes
pathology:
loss
function
C9ORF72
protein,
generation
RNA
foci,
production
dipeptide
repeat
(DPRs).
this
review,
we
discuss
role
autophagy-lysosome
(ALP),
present
recent
research
deciphering
how
dysfunction
ALP
synergizes
with
haploinsufficiency,
which
together
gain
mechanisms
involving
expansions
DPRs,
drive
process.
This
review
delves
further
into
interactions
RAB
endosomal/lysosomal
trafficking,
their
regulating
various
steps
lysosomal
pathways.
Lastly,
aims
provide
framework
investigations
C9ORF72-linked
ALS-FTD
well
other
diseases.
Cell Death Discovery,
Год журнала:
2023,
Номер
9(1)
Опубликована: Июль 12, 2023
Abstract
Pulmonary
hypertension
(PH)
is
a
clinical
and
pathophysiological
syndrome
caused
by
changes
in
pulmonary
vascular
structure
or
function
that
results
increased
resistance
arterial
pressure,
it
characterized
endothelial
dysfunction,
artery
media
thickening,
remodeling,
right
ventricular
hypertrophy,
all
of
which
are
driven
an
imbalance
between
the
growth
death
cells.
Programmed
cell
(PCD),
different
from
necrosis,
active
cellular
mechanism
activated
response
to
both
internal
external
factors
precisely
regulated
More
than
dozen
PCD
modes
have
been
identified,
among
apoptosis,
autophagy,
pyroptosis,
ferroptosis,
necroptosis,
cuproptosis
proven
be
involved
pathophysiology
PH
varying
degrees.
This
article
provides
summary
regulatory
patterns
their
potential
effects
on
PH.
Additionally,
describes
current
understanding
this
complex
interconnected
process
analyzes
therapeutic
targeting
specific
as
molecular
targets.